doxepin has been researched along with Seasonal Affective Disorder in 1 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Seasonal Affective Disorder: A syndrome characterized by depressions that recur annually at the same time each year, usually during the winter months. Other symptoms include anxiety, irritability, decreased energy, increased appetite (carbohydrate cravings), increased duration of sleep, and weight gain. SAD (seasonal affective disorder) can be treated by daily exposure to bright artificial lights (PHOTOTHERAPY), during the season of recurrence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "30 inpatients suffering from major depression (DSM-III-R), who did not fulfill the criteria of seasonal affective disorder (SAD), were treated with either doxepin or amitripytyline as monotherapy and supportively with bright light for 14 days." | 5.08 | Does bright-light therapy influence autonomic heart-rate parameters? ( Kaschka, WP; Rechlin, T; Schneider, K; Weis, M; Zimmermann, U, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rechlin, T | 1 |
| Weis, M | 1 |
| Schneider, K | 1 |
| Zimmermann, U | 1 |
| Kaschka, WP | 1 |
1 trial available for doxepin and Seasonal Affective Disorder
| Article | Year |
|---|---|
Does bright-light therapy influence autonomic heart-rate parameters?
Topics: Adult; Aged; Amitriptyline; Autonomic Nervous System; Combined Modality Therapy; Doxepin; Female; He | 1995 |